Abstract
For scale-intensive industries and science-based industries in Germany, we investigate the question whether firms combining internal R&D and acquisition of capital with embodied technology demonstrate better product and process innovation performance than companies using only one of those innovation strategies. Our approach comprises both indirect and direct complementarity tests between those two innovation activities. The empirical results suggest that the combination strategy provides a distinct advantage to companies both in producing product and process innovations. In particular, in product innovations, firms demonstrate a higher novelty degree of their goods, while in process innovations they provide a higher quality improvement (in the science-based industries only) and a significant cost reduction (in the science-based and scale-intensive industries).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
